Dr Ana Topf Dr Jennifer Duff Dr Richard Charlton Professor Volker Straub
| Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure | 2023 |
|
Dr Sabine Specht Dr Jennifer Duff Dr Richard Charlton Dr Tuomo Polvikoski Dr Rita Barresi et al. | A cryptic intronic LAMA2 insertion in a boy with mild congenital muscular dystrophy type 1A | 2021 |
|
Daniel Cox Professor Giorgio Tasca Dr Richard Charlton
| INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH | 2021 |
|
Professor Roger Whittaker Dr Richard Charlton Dr Rita Barresi Professor Hanns Lochmuller Professor Rita Horvath et al. | Inherited neuropathies with predominant upper limb involvement: genetic heterogeneity and overlapping pathologies | 2020 |
|
Dr Lizzie Harris Professor Chiara Marini Bettolo Dr Ana Topf Dr Rita Barresi Dr Tuomo Polvikoski et al. | MEGF10 related myopathies: A new case with adult onset disease with prominent respiratory failure and review of reported phenotypes | 2018 |
|
Dr Andreas Roos Daniel Cox Professor Chiara Marini Bettolo Dr Rita Barresi Dr Richard Charlton et al. | Mutations in INPP5K, Encoding a Phosphoinositide 5-Phosphatase, Cause Congenital Muscular Dystrophy with Cataracts and Mild Cognitive Impairment | 2017 |
|
Dr Richard Charlton Professor Michela Guglieri Emerita Professor Katherine Bushby Professor Volker Straub Dr Rita Barresi et al. | The importance of dosage analysis in dysferlinopathy | 2015 |
|
Dr Richard Charlton Emerita Professor Katherine Bushby Dr Rita Barresi
| The National Diagnostic and Advisory Service for Limb-Girdle Muscular Dystrophies in Newcastle | 2014 |
|
Dr Liesbeth De Waele Dr Michelle Eagle Dr Richard Charlton Dr Langping He Dr Emma Watson et al. | Recessive desmin-null muscular dystrophy with central nuclei and mitochondrial abnormalities | 2013 |
|
Dr Richard Charlton Professor Volker Straub Professor Hanns Lochmuller Emerita Professor Katherine Bushby Dr Rita Barresi et al. | A single in-frame deletion in the CAPN3 gene is linked to muscular dystrophy with a dominant pattern of inheritance | 2012 |
|
Dr Anna Sarkozy Dr Michelle Eagle Dr Richard Charlton Dr Rita Barresi Professor Hanns Lochmuller et al. | Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene | 2011 |
|
Dr Lars Klinge Dr Richard Charlton Dr Steven Laval Dr Mark Hornsey Professor Volker Straub et al. | Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle | 2010 |
|
Dr Richard Charlton Dr Anna Sarkozy Dr Debbie Hicks Emerita Professor Katherine Bushby Dr Rita Barresi et al. | Muscle protein profile in Anoctaminopathies | 2010 |
|
Dr Lars Klinge Dr Michelle Eagle Dr John Hudson Dr Anna Sarkozy Dr Richard Charlton et al. | New aspects on patients affected by dysferlin deficient muscular dystrophy | 2010 |
|
Yen-Hui Chiu Dr Mark Hornsey Dr Lars Klinge Dr Louise Jorgensen Dr Steven Laval et al. | Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy | 2009 |
|
Dr Steven Laval Dr Louise Jorgensen Dr Mark Hornsey Dr Lars Klinge Dr Richard Charlton et al. | Attenuated muscle regeneration is a key factor in dysferlinopathy | 2009 |
|
Dr Richard Charlton Dr Debbie Hicks Dr Mojgan Reza Professor Volker Straub Professor Hanns Lochmuller et al. | Chain-specific antibody testing of collagen VI: An additional pre-screening strategy for the diagnosis of Bethlem myopathy | 2009 |
|
Dr Richard Charlton Professor Volker Straub Emerita Professor Katherine Bushby Dr Rita Barresi
| Immunohistochemical analysis of calpain 3: Advantages and limitations in diagnosing LGMD2A | 2009 |
|
Dr Debbie Hicks Dr Anne Lampe Dr Rita Barresi Dr Richard Charlton Professor Hanns Lochmuller et al. | A refined diagnostic algorithm for Bethlem myopathy | 2008 |
|
Dr Richard Charlton Dr Rita Barresi Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub et al. | Caveolinopathy - New mutations and additional symptoms | 2008 |
|
Dr Rita Barresi Dr Richard Charlton Professor Volker Straub
| D.P.3.04: Inclusion body myopathy with Paget's disease and frontotemporal dementia (IBMPFD): Extending the clinical features in a large pedigree | 2008 |
|
Dr Rita Barresi Dr Richard Charlton Dr Michelle Eagle Emerita Professor Katherine Bushby Professor Volker Straub et al. | D.P.3.09: Caveolinopathy - New mutations and additional symptoms | 2008 |
|
Dr Richard Charlton Dr Rita Barresi Professor Volker Straub
| D.P.3.10: Partial caveolin 3 deficiency in acquired rippling muscle disease | 2008 |
|
Dr Anne Lampe Dr Debbie Hicks Dr Steven Laval Dr Richard Charlton Professor Volker Straub et al. | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance | 2008 |
|
Dr Julie Murphy Dr Richard Charlton Dr Rita Barresi Emerita Professor Katherine Bushby Professor Robert Taylor et al. | G.P.10.09 Mitochondrial dysfunction in dysferlinopathy | 2008 |
|
Dr Richard Charlton Emerita Professor Katherine Bushby Dr Rita Barresi
| G.P.14.01: Immunohistochemical analysis of calpain 3: Advantages and limitations in diagnosing LGMD2A | 2008 |
|
Dr Lars Klinge Dr Richard Charlton Dr Juliane Mueller Dr Louise VB Anderson Professor Volker Straub et al. | Late onset in dysferlinopathy widens the clinical spectrum | 2008 |
|
Dr Lars Klinge Dr Richard Charlton Dr Rita Barresi Emerita Professor Katherine Bushby Professor Volker Straub et al. | Sarcoglycanopathies: Can muscle immunoanalysis predict the genotype? | 2008 |
|
Dr Richard Charlton Dr Rita Barresi Dr Louise VB Anderson Dr Michelle Eagle Dr Mauro Santibanez Koref et al. | Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A | 2007 |
|
Dr Lars Klinge Professor Robin Harris Dr Richard Charlton Professor Volker Straub Dr Rita Barresi et al. | Dysferlin in muscle regeneration | 2007 |
|
Dr Lars Klinge Dr Richard Charlton Dr Rita Barresi Emerita Professor Katherine Bushby
| Dysferlinopathy with very late onset and untypical clinical presentation | 2007 |
|
Dr Anne Lampe Dr Debbie Hicks Dr John Hudson Dr Steven Laval Dr Richard Charlton et al. | Development of a diagnostic algorithm for patients with a Bethlem myopathy clinical phenotype | 2006 |
|
Dr Anna Sarkozy Dr Richard Charlton Dr Michelle Eagle Professor Patrick Chinnery Professor Volker Straub et al. | Phenotypic variability associated with desmin gene mutations | 2006 |
|
Dr Richard Charlton Dr Lars Klinge Emerita Professor Katherine Bushby Professor Volker Straub
| Sarcoglycanopathy - Can immunoanalyses accurately predict the genotype? | 2006 |
|
Evelyn Torsney Dr Richard Charlton Professor Sir John Burn Professor Helen Arthur
| Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality | 2003 |
|
Evelyn Torsney Dr Richard Charlton Professor Helen Arthur
| Inducible expression of human endoglin during inflammation and wound healing in vivo | 2002 |
|
Garrett Durkan Dr Richard Charlton Dr Mary Robinson Kilian Mellon
| Caveolin-1 expression is associated with high-grade bladder cancer | 2001 |
|
Dr Alaiyi West Dr Marie O'Donnell Dr Richard Charlton Professor David Neal Professor Hing Leung et al. | Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer | 2001 |
|
Evelyn Torsney Dr Richard Charlton Professor Helen Arthur
| Endoglin, a gene required for murine embryonic vasculogenesis, is upregulated in angiogenesis in human inflammatory disease: Studies using a 'knockout' mouse model (the 'Cookson Mouse') | 2001 |
|
Dr Richard Charlton
| Transforming growth factor beta1 (TGF-beta 1) expression by myofibroblasts in dermal wound healing | 2001 |
|
Evelyn Torsney Dr Richard Charlton Professor Helen Arthur
| An antibody to Endoglin/CD105 (SN6h): A marker for endothelial cells in chronic inflammatory disease | 2000 |
|
Dr Richard Charlton
| Novel endothelial cell markers are expressed in angiogenesis in human atherosclerosis | 1999 |
|
Dr Richard Charlton
| The expression of C5a receptor (C5aR) (CD88) is associated with the progression of inflammation in human disease | 1999 |
|